Introduction
(AAV) are emerging as promising vehicles which may The human photoreceptor cell is a specialized neuron overcome some of the limitations of other viral syswhich is the critical site of cellular dysfunction in retinitis tems. 10, 11 The AAV genome is a linear single-stranded pigmentosa (RP), the most prevalent group of retinal gen-DNA molecule of 4680 nucleotides, but, for the purposes etic diseases. RP is characterised by the development of of gene transfer, the viral genes may be removed leaving night blindness due to the progressive loss of the rod only the 145-base inverted terminal repeat sequences photoreceptors, leading to contraction of the visual fields, (ITRs) flanking the transgene construct. The ITRs are sufand reduced or absent electroretinogram. RP affects up ficient to ensure packaging of inserted DNA into infecto one in 3000 in the populations studied, 1, 2 and is clinitious virions when AAV and adenoviral helper functions cally and genetically heterogeneous, with autosomal are provided in trans. As a potential vector for gene therdominant and recessive, as well as several X-linked apy, AAV has the further advantages that human infecforms. More than 30 chromosomal loci associated with tion has not been associated with any disease, the virus RP and other retinal diseases have been mapped, 3 and is capable of efficiently infecting both dividing and postmutations in at least 10 genes identified. Consequent on mitotic cells including neurons, and is able to persist in these findings is the possibility of treating certain of these cells for long periods. Presently, AAV-based gene transdiseases by delivering a functional gene directly to the fer protocols are under evaluation preclinically for sevaffected cells.
eral genetic diseases, including haemolytic anaemias, and At present, viral vectors are the most efficient gene at the clinical level for cystic fibrosis.
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transfer vehicles for neural retina transduction. We and others have demonstrated the ability of AAV Replication-defective adenoviruses can efficiently deliver to mediate reporter gene transfer to the retina. [12] [13] [14] We genes to retinal cells in vivo, [4] [5] [6] and complementation of have proceeded to evaluate a recombinant AAV (rAAV) the mutant gene via adenovirus-mediated delivery to the construct in a model of degenerative retinal disease, the retinal degeneration (rd) mouse eye can slow the rate of rd mouse. In homozygous (rd/rd) animals, degeneration photoreceptor loss in this model. 7 However, adenoof the rod photoreceptors occurs during the first 3 postviruses are naturally pathogenic in humans, and their use natal weeks of life, due to recessive mutation of the ␤-as gene transfer vehicles has been complicated by adverse subunit of the visual transduction enzyme, cGMP phosimmunological reactivity and cytotoxicity, 8 including folphodiesterase (PDE). 15 The production of a truncated lowing intravitreal injection in dogs. 9 PDE-␤ protein causes loss of function of the holoenzyme, resulting in elevated retinal cGMP and leading to rapid photoreceptor degeneration. The relevance of this model to understanding human retinal degenerations has been and the ␣-subunit of PDE in families with recessively injected eyes, slight PDE immunoreactivity was detected in the outer and inner plexiform layers (Figure 3a ). Simiinherited RP. 16, 17 In addition, transgenic rd/rd mice in which expression of wild-type, bovine PDE-␤ was tarlar results were obtained in the PBSS-injected eyes (data not shown). In contrast, up to three rows of photorecepgeted to the photoreceptors using the opsin promoter, showed rescue of these cells from degeneration. 18 This tor nuclei were observed in retinas of AAV.PDE-␤-injected animals, and increased PDE immunostaining suggested that an approach using somatic delivery of the corrective gene might also provide a therapeutic effect.
was observed in the outer and inner plexiform layers, and at the nerve fibre layer (Figure 3b ). In parallel studies We have constructed a rAAV to deliver the human PDE-␤ cDNA, under the control of a segment of the murine (unpublished), AAV-mediated delivery of the lacZ reporter gene was examined in rd mice, using similar opsin promoter, to the retinas of degenerative rd mice and control strains, and used a series of evaluative measviral titres and injection and analytical protocols. We found no evidence of rescue of photoreceptors in these ures to establish the potential for this approach to mediate rescue of the degenerative photoreceptors, partreated eyes by either histological or electrophysiological assessments. ticularly in terms of their functional response to light.
We examined the expression of the PDE-␤ transgene at the mRNA level using the reverse transcription polyResults merase chain reaction (RT-PCR) technique. Following amplification the PCR products were separated by agaExpression of the transgene rose gel electrophoresis in the presence of ethidium broThe plasmid pTOP8 (Figure 1 ), containing the full-length mide. The gel was then blotted and hybridized with a human PDE-␤ cDNA driven by 1.4 kb of the murine human PDE-␤ cDNA probe to confirm that the positive opsin promoter, was used to generate the AAV.PDE-␤ reactions corresponded to specific amplification from the for intravitreal injection. Expression of the PDE-␤ transtransgene. As shown in Figure 4 , expression was detectgene was initially evaluated following treatment of adult able in retinas from AAV.PDE-␤-injected eyes, in both nondegenerative (rd/+) animals. PDE protein expression rd/rd and C57BL/6 mice, at up to 6 weeks after injection, was detected by immunocytochemistry on frozen tissue the latest time-point studied. Non-injected and PBSSsections using a rabbit polyclonal anti-PDE antibody (a injected control eyes were negative for transgene gift of Dr Y-K Ho, University of Illinois, Chicago) ( Figure  expression . To assess the possibility of AAV-mediated 2). This antibody does not distinguish between the mouse gene transfer to extraocular tissues, the analysis was also and human proteins, and reacts strongly with the ␣-and performed on total RNA from the brain, liver, heart and ␤-subunits and weakly with the ␥-subunit of the lung of virus-injected animals, also at 6 weeks after injecenzyme. 19 Endogenous PDE protein was detected at the tion. No expression of the transgene was detectable in outer segments of the photoreceptors in untreated rd/+ any of these tissues (data not shown). That negative retina (Figure 2a) . Following AAV.PDE-␤ injection, results were not due to degradation of RNA was deterimmunoreactivity was similarly observed at the photoremined by separate RT-PCR experiments in which the ceptor outer segments but with much greater intensity of detection of transferrin receptor mRNA was confirmed staining (Figure 2b ). Most interestingly, in the vicinity of (not shown). the injection site, intense immunostaining extending from the photoreceptor nuclei to the outer segments was
In vitro electroretinography observed. Slight immunoreactivity was detected at the To determine the therapeutic effect of transgene plexiform layers and nerve fibre layer in both injected expression on retinal function, we used an in vitro electroand non-injected animals. Control sections lacking priretinography assay to measure the responsiveness of the mary antibody displayed none of the above reactivity retina to light. Retinas from untreated control C57BL/6 (data not shown). mice (n = 4), and from rd/rd non-injected (n = 23), PBSSIn the homozygous rd mouse, the effect of the mutant injected (n = 4) and AAV.PDE-␤-injected (n = 23) animals PDE-␤ gene results in only one row of photoreceptor cell were compared. Since individual variation in fast PIII nuclei remaining at 21 days after birth (Figure 3a ) comresponse amplitudes has been reported, 20 the data were pared with eight to 10 rows in the heterozygote. 15 In nonnormalized to facilitate comparison. The PIII amplituderesponse curves (V-log I function) for the tested retinas are illustrated in Figure 5 . The fast PIII responses from control C57BL/6 retinas reached saturation (V max ) at a light intensity 1.2 log units less than in the rd/rd control and injected mice. Fast PIII response threshold in rd/rd animals was 1.2 log units higher than in control C57BL/6. The reduced sensitivity of the non-injected rd/rd retinas to light compared with the non-injected C57BL/6 is demonstrated by a shift of the V-log I function of the rd/rd retinas to the right, with a 1.99 log unit decrease in the trol non-injected or PBSS-injected mice (P Ͻ 0.005). This 
Figure 3 Immunostaining for PDE in 10 m frozen retinal sections of 21-day-old rd/rd mice. Sections from non-injected (a) and AAV.PDE-␤-injected (b) animals. Note increased thickness of photoreceptor outer nuclear layer (arrows) in (b). Original magnification × 1720.
animals ( Figure 6a ). The electron microscopy examination confirmed this difference. In virus-treated retinas, the inner photoreceptor segments showed characteristic accumulation of mitochondria and Golgi cisternae ( Figure 7 ). In addition, compact piles of disc structures were frequently observed in outer photoreceptor segments of the treated animals ( We report here the first demonstration that an AAV vec- response can be rescued following injection of a human PDE-␤ AAV construct in the rd/rd mouse model of inherited retinal degeneration, and this rescue is correlated with increased survival of photoreceptors. During the course of our study, a similar approach using adenovirus-mediated transfer in the rd mouse was reported.
7 However, the disadvantages of adenoviruses have been indicated, and further, while slowing of degeneration occurred, the function of the residual photoreceptors was not investigated. Additionally, the expression of the PDE-␤ was driven by the cytomegalovirus (CMV) immediate-early promoter, which is not specific for photoreceptor cells.
We have designed a rAAV construct in which expression of human PDE-␤ is driven by a 1.4 kb promoter segment of the photoreceptor-specific murine opsin gene, in order to attempt to counteract the damaging effect of the mutated endogenous protein in the rd investigation, intraocular delivery of the AAV.PDE-␤ construct in the nondegenerative rd/+ heterozygote results in a higher level of immunodetectable PDE at the difference corresponds to an approximately two-fold increase in sensitivity of the retinas from AAV.PDE-␤-photoreceptor outer segments, as well as at the photoreceptor nuclei level, in comparison with controls. These treated versus control rd/rd eyes. results suggest that the rAAV construct is capable of transducing murine photoreceptors. Elevated PDE proHistological analyses To assess whether the enhanced light sensitivity of the tein expression is also observed in AAV.PDE-␤-injected rd/rd animals, though to a lesser degree, presumably due treated rd/rd retinas correlated with histomorphological characteristics, retinas used for in vitro electroretinoto still-extensive outer segment loss. However, the different localization, in the plexiform layers and nerve fibre graphy were subsequently examined by light and electron microscopy ( Figures 6 and 7) . Incubation of isolated layer, may be due to the loss of structural and biochemical polarity of the photoreceptor cells undergoing retinas in the Krebs-buffer medium was somewhat detrimental to morphological preservation (Figure 6a, b) , comdegeneration in this model, as previously postulated. 22 Misrouting of the visual transduction proteins rhodopsin, pared with retinas fixed immediately after killing ( Figure  6c, d) . However, no morphological differences were transducin and PDE has also been reported in transgenic mice carrying a mutant rhodopsin gene. 21 At the tranobserved in PBSS-injected animals (Figure 6d ), in comparison with control, non-injected animals (Figure 6c ). scriptional level, in situ hybridization for transgene mRNA will assist in verifying constraint of expression to Notably, in AAV.PDE-␤-injected rd/rd eyes, the number of rows of photoreceptor nuclei (3-4, Figure 6b) was the surviving photoreceptors, since promoter specificity may be influenced by somatic versus germline delivery. increased approximately two-fold compared with noninjected eyes (1-2, Figure 6a ). No significant difference It is nevertheless likely that the increased PDE immunoreactivity in rAAV-injected eyes results from translation was observed at the inner nuclear layer level. Photoreceptor segments were frequently detectable by light of transgene mRNA, and transcripts remain detectable for at least 6 weeks after administration in both heteromicroscopy in AAV.PDE-␤-treated animals (Figure 6b ), compared with only isolated instances in non-injected zygous and homozygous mice. Taken together, these results confirm that the AAV.PDE-␤ vector is able to ment with the approximate doubling of the number of photoreceptor nuclear layers across much of the treated transfer and express the transgene in vivo in the murine retina.
retinas. Our present study provides an evaluation of the functional rescue at a single dose and early post-injection Compared with non-injected and vehicle-injected animals, AAV.PDE-␤-injected rd/rd mouse retinas have a time-point, but clearly dose-response and time-course experiments will be needed to determine the maximum greater survival of photoreceptor cells, which correlates with preservation of retinal function as assessed by elecand long-term functional recovery in this mouse model. Wild-type AAV is capable of integrating into the host troretinography. This was not due to a nonspecific influence of injection since neither virus suspension buffer nor genome following infection, 10,11 primarily in a sitespecific manner at chromosome 19 in human cells. The (in previous studies) similar doses of AAV-lacZ, were found to have any detectable rescue effect. The increased possibility of recombinant AAV integration in vivo remains to be evaluated, although in vivo persistence in amount of outer segment material in AAV.PDE-␤-treated animals implies that there are more photoreceptor Na + part as an episome has recently been reported. 24 In our study, all treated animals remained clinically healthy channels, capable as a result of higher photocurrents and increased V max for a light stimulus of given intensity. The throughout the experiments, suggesting that AAV.PDE-␤ was not acutely toxic at the dose used. It will neverthedecreased semi-saturation luminance further suggests an increase in retinal quantal catch, and greater light sensiless be important to assess the need for and possibility of repeated delivery of the vector and to determine any tivity indicates a higher level of rhodopsin in photoreceptors of rAAV-injected rd/rd mice. A 1.0 log unit loss of potential humoral immune response. Indeed, a more thorough evaluation of safety, toxicity and host response sensitivity has been shown to correspond to a loss of approximately 50% of rhodopsin. 23 Therefore, the extent aspects will be required, as has been done for in vivo delivery of the cystic fibrosis transmembrane regulator of rescue could be estimated to be about 17% of the normal (C57BL/6) photoreceptor function in rAAV-injected (CFTR) gene. 24 In particular, the possibility that the recombinant virus may be systemically spread should be rd/rd animals. This corresponds to an approximately twofold increase in light sensitivity of the retina, in agreeassessed by analysing the vector DNA distribution and cassette was then cloned into the AAV vector pTR (source: Dr N Muzyczka, University of Florida, Gainesville, USA). The structure and orientation of the final construct (pTOP8, Figure 1 ) were confirmed by restriction digest analysis.
Preparation of the recombinant AAV Recombinant AAV virions were produced using standard protocols. 28 Briefly, the insert and ITRs of pTOP8 were packaged into AAV particles by complementation with a system expressing AAV rep and cap genes in adenovirus (Ad5ts149)-infected 293 cells (ECACC, Salisbury, UK). Recombinant virus was then harvested, purified by double caesium chloride density gradient centrifugation, dialysed, and the viral titre determined by infectious centre assay. 29 No helper adenovirus was detectable in purified rAAV by immunocytochemistry using anti-adenoviral antibody (Chemicon International, Harrow, UK) on AAV-infected 293 cells.
Virus delivery
All animal procedures were carried out in accordance with the requirements of a Home Office Licence. Eightday-old C57BL/6, rd/+, and rd/rd mice, anaesthetized limbus. Virus resuspension buffer (phosphate-buffered saline containing sucrose at 5% w/v; PBSS) was used for control injections. One eye only was injected per animal, potential pathological effects. While our initial studies the other serving as an untreated control. did not detect any transgene expression in extraocular tissues, there may, nevertheless, be extraocular infection Immunocytochemistry by rAAV without expression, and, given the possibility of Enucleated eyes were fixed in fresh 4% paraformalinsertional mutagenesis following integration, this aspect dehyde in 0.1 m phosphate buffer overnight, embedded must be more thoroughly examined. Evaluation of the and frozen. 30 Cryostat sections (10 m) were processed inflammatory cytokines IL-6 or IL-8 will also give an estifor immunocytochemistry using the classical peroxidasemation of the cellular immunological response, and seroanti-peroxidase technique. 31 Primary antibody (1:500 positivity for AAV will be established before and after dilution) used was a polyclonal anti-PDE (gift from Dr rAAV injections. One further aspect to be considered is Y-K Ho, Chicago, USA). that mobilization of the CFTR rAAV has been described in vitro. 24 However, Afione and collaborators 25 have Reverse transcription PCR shown that vector rescue rarely occurs following in vivo Total RNA was isolated from dissected, frozen retinas wild-type AAV2 and adenovirus coinfection. Nevertheand portions of extraocular tissues using an RNeasy kit less, it will be essential to determine potential rescue and (Qiagen, Crawley, UK), and treated with DNaseI spread to other organs in animals intraocularly injected (Pharmacia Biotech, St Albans, UK) to degrade genomic with AAV.PDE-␤. These initial issues should be carefully DNA. Samples were then reverse transcribed in 20 l examined in appropriate models to constitute the basis reactions using 3.8 units of AMV reverse transcriptase of preclinical studies towards eventual clinical trials.
(Promega, Southampton, UK) and specific antisense primer APDETG (5' CTGGAATTCGGCTTGTCCCCAC-GGGACCAGT 3′), for 90 min at 42°C, followed by heat
Materials and methods
inactivation of the enzyme. Controls for genomic DNA contamination were identically processed but in the Assembly of the pTOP8 plasmid The human PDE-␤ cDNA full-length coding sequence absence of enzyme. Primers for amplification of the transgene were MUSOPS4: 5′ AGCTCGCCAAGCAGCwas amplified by ligation PCR from two cDNA clones 26 (gift of Dr M Hayden, University of British Columbia, CTTGGT 3′ and HPDE6: 5′ CCTTGAAGACCAC-GCGCTCCA 3′. Amplifications were performed in 30 l Vancouver, Canada), using sequence-specific primers and 28 cycles of PCR amplification. The resulting 2.6 kb reactions using 0.75 units Taq polymerase (GibcoBRL, Paisley, UK) in a thermal cycler (Hybaid, Teddington, product was cloned into the vector pCRII (Invitrogen BV, Leek, The Netherlands) and then transferred into plasmid UK) with initial denaturation of 94°C for 3 min, followed by cycling parameters of (94°C 45 s, 56°C 45 s, 72°C 30 pRho4-4 containing 4.4 kb of the murine opsin promoter 27 
In vitro electroretinography
Adeno-associated virus delivery of an opsin promoter driven
In vitro electroretinography was performed using the 
